Evidence map›Paper›PMID 29769200›Full record

ArticleCancer research2018

Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition.

Natividad R Fuentes, Mohamed Mlih, Rola Barhoumi, Yang-Yi Fan, Paul Hardin, Trevor J Steele, Spencer Behmer, Ian A Prior, Jason Karpac, Robert S Chapkin

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Eicosapentaenoic Acid InhibitsBiomolecules · 2021
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Natividad R FuentesProgram in Integrative Nutrition and Complex Diseases, Texas A&M University, College Station, Texas.ORCID 0000-0001-9571-808X
Mohamed MlihDepartment of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Sciences Center, College Station, Texas.ORCID 0000-0003-3491-9616
Rola BarhoumiDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas.
Yang-Yi FanProgram in Integrative Nutrition and Complex Diseases, Texas A&M University, College Station, Texas.
Paul HardinDepartment of Biology, Texas A&M University, College Station, Texas.
Trevor J SteeleDepartment of Entomology, Texas A&M University, College Station, Texas.
Spencer BehmerDepartment of Entomology, Texas A&M University, College Station, Texas.
Ian A PriorDivision of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom.
Jason KarpacDepartment of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Sciences Center, College Station, Texas.
Robert S ChapkinProgram in Integrative Nutrition and Complex Diseases, Texas A&M University, College Station, Texas. r-chapkin@tamu.edu.ORCID 0000-0002-6515-3898
Texas A&M University · USTexas A&M Health Science Center · USUniversity of Liverpool · GB

Funding

Plasma membrane therapy: Disruption of Wnt associated receptor spatiotemporal organization by membrane targeted dietary bioactives (MTDB)R35CA197707 · NCI · TEXAS A&M AGRILIFE RESEARCH · PI CHAPKIN, ROBERT STEPHEN · 2016 to 2022
$6.3M
Regulatory Science in Environmental Health and ToxicologyT32ES026568 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu, Natalie M Johnson · 2016 to 2026
$3.8M
TARGETED GENOMICS FACILITY COREP30ES023512 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI DEUTZ, NICOLAAS E · 2014 to 2017
$3.3M
NCI NIH HHS R35 CA197707NIEHS NIH HHS P30 ES023512NIEHS NIH HHS T32 ES026568
6 · The paper itself

Abstract

Ras signaling originates from transient nanoscale compartmentalized regions of the plasma membrane composed of specific proteins and lipids. The highly specific lipid composition of these nanodomains, termed nanoclusters, facilitates effector recruitment and therefore influences signal transduction. This suggests that Ras nanocluster proteolipid composition could represent a novel target for future chemoprevention interventions. There is evidence that consumption of fish oil containing long-chain n-3 polyunsaturated fatty acids (n-3 PUFA) such as eicosapentaenoic acid (EPA, 20:5

Indexed as

AnimalsCell MembraneCell ProliferationCells, CulturedCholesterolDietDocosahexaenoic AcidsDrosophilaEicosapentaenoic AcidFatty Acids, Omega-3Fish OilsMicePhospholipidsProteolipidsProto-Oncogene Proteins p21(ras)CholesterolDocosahexaenoic AcidsEicosapentaenoic Acideicosapentaenoic acid ethyl esterFatty Acids, Omega-3Fish OilsHras protein, mousePhospholipidsProteolipidsProto-Oncogene Proteins p21(ras)

Identifiers

PMID29769200
PMCPMC6050089
OpenAlexW2803768714

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.